News

Oculogica Adds to IP Portfolio with Patent for Glaucoma

Oculogica, the leader in non-invasive assessment of concussion, announces today the granting of U.S. Patent No. 10,863,902 by the U.S. Patent and Trademark Office. This patent protects Oculogica’s method and system for assessing glaucoma in a patient using a noninvasive eye tracking system.

Read More →

Oculogica’s Drs. Rosina and Uzma Samadani Named in Fast Company’s Annual List of the Most Creative People in Business

Oculogica Founder, Dr. Uzma Samadani and CEO, Dr. Rosina Samadani, join the 11th annual list of women and men from such companies as Netflix, Google, and Patagonia, as well as institutions such as Johns Hopkins University and the ACLU of Massachusetts.

Read More →

These sisters invented a better way to diagnose concussions by tracking eye movement

Last year, the FDA granted authorization for commercial use of the first tool that provides an objective diagnosis of concussions. Called EyeBox, it was developed by sisters Uzma and Rosina Samadani.

Read More →

EyeBOX Featured in Weekly Interview with The Daily Show’s Trevor Noah & Microsoft President Brad Smith

Watch our EyeBOX technology featured in Trevor Noah’s and Microsoft President Brad Smith’s discussion with Green Bay Packers President & CEO Mark Murphy.

Read More →

Midwest Orthopaedics at Rush Acquires New Eye Tracking Technology to Better Assess Concussion

Midwest Orthopaedics at Rush (MOR) is the first in Illinois to offer a new eye-tracking technology to more quickly identify a patient with ocular changes after a potential concussion or traumatic brain injury.

Read More →

TitletownTech leads $8 million round of funding for Oculogica

TitletownTech today announced it has invested in Oculogica, an innovative digital health company, by leading an $8 million round of funding that recently closed.

Read More →

Their device promises faster and more accurate concussion assessments. A venture fund started by the Green Bay Packers took notice.

A venture fund led by the Green Bay Packers and Microsoft has invested in a new technology that promises to provide a major advance in the diagnosis of concussions.

Read More →

Neurosurgeon Leads the Way in Eye Tracking Diagnosis for Concussion

From the age of six, Dr. Uzma Samadani, MD, Ph.D, knew she wanted to be a doctor.

Read More →

Oculogica Announces New Category 3 CPT Code Created by American Medical Association

Oculogica, Inc., a pioneer in algorithm-based neuro-diagnostics for brain health, announced today that the American Medical Association (AMA) has confirmed the addition of a new Category 3 CPT Code, 0X17T, Eye movement analysis test without spatial calibration, allowing clinicians to appropriately report the services related exclusively to the Oculogica EyeBOX® exam.

Read More →

FDA: The FDA Recommends Only Using Cleared or Approved Medical Devices to Help Assess or Diagnose a Head Injury, Including Concussion: FDA Safety Communication

Certain products intended to aid in the assessment, diagnosis, or management of a head injury, which includes concussion, traumatic brain injury (TBI), and mild traumatic brain injury (mild TBI or mTBI) are considered medical devices regulated by the FDA.

Read More →

Recent Blog Posts

New posts coming soon

Archives
Scroll to Top